Further CYP-001 GvHD Clinical Data Published in Nature Medicine
/PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics,...
Stay updated with breaking news from John Rasko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics,...
It's time for some of the world's best hospitals and research institutes to launch full and independent investigations into their support for disgraced transplant surgeon Paolo Macchiarini, argue experts in The BMJ today. Responses from those concerned are also published.
Paolo Macchiarini misled the world over his breakthroughs in regenerative medicine, but why did most of the institutions that supported him bear no responsibility for hosting a rogue stem cell surgeon? It’s time for them to launch full and independent investigations, argue John Rasko and Carl Power By 2008 it looked like a medical revolution was under way. Before us lay a new world, where any injured organ could be replaced with one custom-made in the laboratory. Leading us there was the charismatic Italian surgeon Paolo Macchiarini, who’d begun replacing damaged windpipes with tissue eng...
It’s time for some of the world’s best hospitals and research institutes to launch full and independent investigations into their support for disgraced transplant surgeon Paolo Macchiarini, argue experts in The BMJ today. Responses from those concerned are also published.
Sydney's Royal Prince Alfred Hospital is part of a groundbreaking new trial aimed at potentially curing Hae...